Cooling survivors of cardiac arrest below normal body temperature does not improve patient survival or recovery.
MRINZ trials win five of the seven Australian Clinical Trials Alliance (ACTA) 2021 Awards
ICU, interview, news, publication, announcement, PleuralDiseaseGuest UserICU, intensive care, awards, Australia, ACTA, PleuralDisease
NZ Asthma Guidelines 2020
Outpatient studies are paused to focus on COVID-19 and ICU studies